Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

The new visual scale is a quick and effective way to measure hair loss in women.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

A boy and his father with hereditary hypotrichosis simplex were treated for hair loss, but the treatment result is unknown.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Timolol eye-drops can cause hair loss.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Some breast cancer chemotherapy can cause permanent hair loss.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Using the right hair care products can improve hair health and help manage hair disorders.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.